Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-transcriptional Regulation of p21

被引:102
作者
Tsuchiya, Naoto [1 ]
Izumiya, Masashi [1 ]
Ogata-Kawata, Hiroko [1 ]
Okamoto, Koji [2 ]
Fujiwara, Yuko [1 ]
Nakai, Makiko [1 ]
Okabe, Atsushi [3 ]
Schetter, Aaron J. [5 ]
Bowman, Elise D. [5 ]
Midorikawa, Yutaka [4 ]
Sugiyama, Yasuyuki [4 ]
Aburatani, Hiroyuki [3 ]
Harris, Curtis C. [5 ]
Nakagama, Hitoshi [1 ]
机构
[1] Natl Canc Ctr, Res Inst, Div Canc Dev Syst, Tsukiji, Japan
[2] Natl Canc Ctr, Res Inst, Div Canc Differentiat, Tsukiji, Japan
[3] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Tokyo, Japan
[4] Teikyo Univ, Sch Med, Univ Hosp, Kawasaki, Kanagawa, Japan
[5] NCI, Human Carcinogenesis Lab, Canc Res Ctr, NIH, Bethesda, MD 20892 USA
关键词
HUMAN CANCER-CELLS; ANIMAL DEVELOPMENT; MICRORNA TARGETS; BREAST-CANCER; GROWTH ARREST; P53; PATHWAY; DNA-DAMAGE; APOPTOSIS; GENE; SENESCENCE;
D O I
10.1158/0008-5472.CAN-10-2475
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Selective activation of p53 target genes in response to various cellular stresses is a critical step in determining the ability to induce cell-cycle arrest or apoptosis. Here we report the identification of the microRNA miR-22 as a p53 target gene that selectively determines the induction of p53-dependent apoptosis by repressing p21. Combinatorial analyses of the AGO2 immunocomplex and gene expression profiles identified p21 as a direct target of miR-22. Induction of p21 was inhibited by miR-22 after exposure to the genotoxic agent Adriamycin (doxorubicin; Bedford Laboratories), sensitizing cells to p53-dependent apoptosis. Interestingly, the activation of miR-22 depended on the intensity of the stresses that induced cells to undergo apoptosis in the presence of p21 suppression. Our findings define an intrinsic molecular switch that determines p53-dependent cellular fate through post-transcriptional regulation of p21. Cancer Res; 71(13); 4628-39. (C)2011 AACR.
引用
收藏
页码:4628 / 4639
页数:12
相关论文
共 50 条
[1]   p21 in cancer: intricate networks and multiple activities [J].
Abbas, Tarek ;
Dutta, Anindya .
NATURE REVIEWS CANCER, 2009, 9 (06) :400-414
[2]   MicroRNAs and other tiny endogenous RNAs in C-elegans [J].
Ambros, V ;
Lee, RC ;
Lavanway, A ;
Williams, PT ;
Jewell, D .
CURRENT BIOLOGY, 2003, 13 (10) :807-818
[3]   Stabilization of wild-type p53 by hypoxia-inducible factor 1α [J].
An, WG ;
Kanekal, M ;
Simon, MC ;
Maltepe, E ;
Blagosklonny, MV ;
Neckers, LM .
NATURE, 1998, 392 (6674) :405-408
[4]   Stress signals utilize multiple pathways to stabilize p53 [J].
Ashcroft, M ;
Taya, Y ;
Vousden, KH .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (09) :3224-3233
[5]   Reversal of human cellular senescence:: roles of the p53 and p16 pathways [J].
Beauséjour, CM ;
Krtolica, A ;
Galimi, F ;
Narita, M ;
Lowe, SW ;
Yaswen, P ;
Campisi, J .
EMBO JOURNAL, 2003, 22 (16) :4212-4222
[6]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[7]   Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs [J].
Chang, BD ;
Xuan, YZ ;
Broude, EV ;
Zhu, HM ;
Schott, B ;
Fang, J ;
Roninson, IB .
ONCOGENE, 1999, 18 (34) :4808-4818
[8]   Widespread microRNA repression by Myc contributes to tumorigenesis [J].
Chang, Tsung-Cheng ;
Yu, Duonan ;
Lee, Yun-Sil ;
Wentzel, Erik A. ;
Arking, Dan E. ;
West, Kristin M. ;
Dang, Chi V. ;
Thomas-Tikhonenko, Andrei ;
Mendell, Joshua T. .
NATURE GENETICS, 2008, 40 (01) :43-50
[9]   Specific activation of the p53 pathway by low dose actinomycin D A new route to p53 based cyclotherapy [J].
Choong, Meng Ling ;
Yang, Henry ;
Lee, May Ann ;
Lane, David P. .
CELL CYCLE, 2009, 8 (17) :2810-2818
[10]  
CORNELIS RS, 1994, CANCER RES, V54, P4200